inositol has been researched along with Agoraphobia in 1 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The frequency and severity of panic attacks and the severity of agoraphobia declined significantly more after inositol than after placebo administration." | 9.08 | Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. ( Aviv, A; Belmaker, RH; Benjamin, J; Fux, M; Levine, J; Levy, D, 1995) |
| "The frequency and severity of panic attacks and the severity of agoraphobia declined significantly more after inositol than after placebo administration." | 5.08 | Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. ( Aviv, A; Belmaker, RH; Benjamin, J; Fux, M; Levine, J; Levy, D, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, J | 1 |
| Levine, J | 1 |
| Fux, M | 1 |
| Aviv, A | 1 |
| Levy, D | 1 |
| Belmaker, RH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder[NCT02811133] | Phase 1/Phase 2 | 0 participants (Actual) | Interventional | 2023-08-31 | Withdrawn (stopped due to Funding terminated) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for inositol and Agoraphobia
| Article | Year |
|---|---|
Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.
Topics: Adult; Agoraphobia; Cross-Over Studies; Double-Blind Method; Female; Humans; Inositol; Male; Panic D | 1995 |